EUVIMEDEUVIMED entdecken
Crossref

72117 De novo belatacept does not reduce skin cancer incidence and burden in renal transplant recipients

Darartu Gamada, Elizabeth Fan, Mateen Motavaf, Sakshi Chopra, Beiyu Liu, Cynthia Green, Melodi Whitley

Journal of the American Academy of Dermatology · 2026-07 · 95 (1) · AB137

DOI: 10.1016/j.jaad.2026.04.554 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-07. Verfasst von Darartu Gamada und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Gamada, D., Fan, E., Motavaf, M., Chopra, S., Liu, B., Green, C., & Whitley, M. (2026). 72117 De novo belatacept does not reduce skin cancer incidence and burden in renal transplant recipients. Journal of the American Academy of Dermatology, 95(1), AB137. https://doi.org/10.1016/j.jaad.2026.04.554

Vancouver

Gamada D, Fan E, Motavaf M, Chopra S, Liu B, Green C, et al. 72117 De novo belatacept does not reduce skin cancer incidence and burden in renal transplant recipients. Journal of the American Academy of Dermatology. 2026;95(1):AB137. doi:10.1016/j.jaad.2026.04.554

BibTeX
@article{Gamada2026,
  author = {Gamada, Darartu and Fan, Elizabeth and Motavaf, Mateen and Chopra, Sakshi and Liu, Beiyu and Green, Cynthia and Whitley, Melodi},
  title = {72117 De novo belatacept does not reduce skin cancer incidence and burden in renal transplant recipients},
  journal = {Journal of the American Academy of Dermatology},
  year = {2026},
  volume = {95},
  number = {1},
  pages = {AB137},
  doi = {10.1016/j.jaad.2026.04.554}
}
Kostenlos starten →